Qiming Venture Partners

Qiming Venture Partners is a prominent venture capital firm based in Shanghai, China, with additional offices in Beijing, Suzhou, and Hong Kong. Founded in 2006, the firm specializes in investing in early to growth-stage companies across various sectors, including healthcare, information technology, consumer products, media, and clean technology. Qiming has established itself as a leading investment firm in China, managing multiple funds with over $1 billion in assets. The firm focuses on supporting innovative entrepreneurs and companies that demonstrate high growth potential, particularly in the technology and healthcare landscapes. Through its strategic investments, Qiming aims to foster the development of new business models and technologies, contributing to the dynamic entrepreneurial ecosystem in China.

Zhang Ao

Executive Director

Artavazd Arumov Ph.D

Principal

Ryan Baker

CFO

Cyrus Chan

Associate

Kan Chen

Partner

Liwen Chen

Associate

Nan Chen

Principal

David Chu

Partner

Phil DiGiacomo

Principal

Anna French

Managing Partner

Yuxin Fu

Associate

Jinda Gao

Principal

Kuantai Yeh

Partner

Robert Headley

Partner

Maykin Ho Ph.D

Venture Partner

William Hu

Managing Partner

Duane Kuang

Founding Managing Partner

Nisa Leung

Managing Partner

Lisa Li

Investor

Dingzheng Li

Vice President

Jing Liu

Associate

Chang Liu

Associate

Bin Liu

Associate

Biao Lu

Associate

Shuo Mao

Principal

Will Mcconnell

Principal

Mark McDade

Co-Founder and Managing Partner

Gary Rieschel

Founder and Managing Partner

Motao Sun

Associate

Amy Tang

Venture Partner

Yi Tang

Principal

Shiyu Wang

Partner

Shiyu Wang

Partner

Bonnie Wang

Principal

Rachel Wang

Venture Partner

Xin Wang

Investor

James Wang

Venture Partner

Gillian Xu

RMB funds CFO

Kuantai Yeh

Partner

Peter (Ming) Yin

Principal, Cleantech

Janet Yu Ph.D

Partner

Liang Yuyu

Managing Partner

Oscar Zhang

Principal

Yafeng Zhou

Associate

Alex Zhou

Managing Partner

Zhiyuan Zhou

Investor

Zhifeng Zhou

Managing Partner

Yiqing Zhu

Associate

Jing-Shan Hu Ph.D

Venture Partner of Healthcare

Phillip DiGiacomo Ph.D

Principal

Past deals in Technology

Bioyond Tech

Series A in 2023
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

CSR Biotech

Seed Round in 2022
Guangzhou Chaoshiji Biotechnology Co., Ltd. (Chaoshiji Technologies) is a high-tech company specializing in the creation and deployment of super-resolution imaging devices for living cells. R&D, production, sales, after-sales, and technical output services for various types of super-resolution optical microscopes are the primary activities. Among the services offered are customized cell sample generation, customized cell sample high-throughput detection, customized cell sample imaging studies, and customized image post-processing and quantitative analysis.

CIX Technology

Seed Round in 2022
CIX Technology develops high-performance, next-generation intelligent computing solutions.

CIX Technology

Angel Round in 2022
CIX Technology develops high-performance, next-generation intelligent computing solutions.

ACXEL

Seed Round in 2022
ACXEL Tech develops large area electronics have given us flat panel displays and flexible, wearable devices. ACXEL takes these ‘active’ pixels and puts them to work transporting liquid droplets – precisely and at amazing speed. Millions of pixels are transformed into tiny engines moving samples around via a high throughput, low cost and programmable platform, offering a wide range of possibilities in chemistry, biology and medtech.

MeetFuture China

Series B in 2022
MeetFuture China is a technology-driven company that supplies automated transmission systems for the pan-semiconductor industry. It provides automation solutions for leading companies in the semiconductor field since 2016 and provided a highly advantageous overall for industrial upgrading and development with independent and controllable core technologies.

Tingsheng Technology

Series A in 2022
TINGSN develops Intracardiac echocardiography (ICE) catheter imaging technology designed to treat cardiac arrhythmia. In addition to ICE products, the company has developed its own heart internal catheter positioning and software algorithms and is developing China first computer surgical simulator for cardiac electrophysiology based on digital heart model.

DPTechnology

Series B in 2021
DPTechnology, founded in 2018 and based in Beijing, China, specializes in micro-scale industrial design through advanced molecular simulation technology. The company has developed a platform that integrates artificial intelligence with molecular simulation algorithms, aiming to enhance industrial and medical research. By providing users with innovative scientific tools, DPTechnology promotes efficiency and creativity in exploring complex research challenges, thereby establishing a new paradigm in both industrial research and clinical applications.

Bioyond Tech

Seed Round in 2021
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

BrainHealth

Series C in 2021
Developer of Tumor-treating Fields technology. The company's products are focused on delivering diagnostic and minimally invasive treatment tools for various brain cancers, enabling healthcare professionals to more effectively treat patients.

MeetFuture China

Series A in 2021
MeetFuture China is a technology-driven company that supplies automated transmission systems for the pan-semiconductor industry. It provides automation solutions for leading companies in the semiconductor field since 2016 and provided a highly advantageous overall for industrial upgrading and development with independent and controllable core technologies.

PR Measurement

Series C in 2021
P&R Measurement Technology Co., Ltd., established in 2011 and based in Zhuhai, China, specializes in the research, development, and application of advanced measurement and control technology. The company provides testing and automation solutions across various sectors, including motors, household appliances, consumer electronics, and energy power. With over 300 independent intellectual property rights, P&R Measurement has earned recognition as a national high-tech enterprise and has received multiple certifications, including ISO9001:2015. The firm focuses on engineering signal processing, acoustic and vibration testing, and structural analysis, offering custom and semi-custom testing equipment and consulting services. P&R Measurement also collaborates with universities and research institutions to enhance its technological capabilities. It operates subsidiaries in multiple locations, including Guangzhou, Suzhou, Hong Kong, and the United States, and has developed comprehensive solutions that are widely acknowledged by industry clients, contributing to its reputation in the testing and automation landscape.

Booming Tech

Series C in 2021
Booming Tech is a cloud-based platform that specializes in game development and virtual reality. It provides tools for creators to design and innovate within virtual environments, catering to various applications, including gaming, industrial simulations, and other immersive experiences. The platform features a robust server architecture that ensures players can engage in real-time, stable interactions regardless of their geographical locations. By focusing on both entertainment and practical applications, Booming Tech supports a diverse range of virtual world creation, enabling users to explore new possibilities in digital interaction.

Weier AI

Series B in 2021
Weier Technology Co., Ltd, also known as Weier Science, designs and develops robots and software. Its human- machine interaction technology caters e-commerce platforms with customer service, sales and marketing, shopping guide, and customer relations management. Weier Technology Co., Ltd was founded in 2016 and is based in Hangzhou, China. Weier Technology operates in the augmented reality and virtual reality industry. The company is based in Shanghai, China.

Yunyinggu

Series D in 2020
Yunyinggu Technology Co., Ltd. is a Chinese start-up focused on the development and promotion of innovative display technologies aimed at enhancing the performance of flat panel displays. The company has created a proprietary solution recognized for achieving superior pixel density, or high pixels per inch (PPI), which can be utilized across various types of flat panels, including LCD, LED, and OLED displays. By advancing display technology, Yunyinggu seeks to contribute to the evolving landscape of visual performance in consumer electronics.

Biren Technology

Series A in 2020
Biren Technology, based in Shanghai, China, specializes in the design and manufacture of intelligent chips and processors tailored for various computing architectures, including GPU and DSA. The company operates in the high-tech sector, focusing on both hardware and software solutions. Its hardware division develops a range of computing solutions that blend versatility with specificity, while its software department is led by experienced industry professionals. The company also conducts frontier research on new intelligent computing systems, emphasizing innovative architectures and advanced compilation technologies. Biren Technology aims to provide integrated solutions for applications such as cloud computing, artificial intelligence training, graphics rendering, and high-performance general-purpose computing, enabling clients to utilize domestic chip solutions and achieve significant technological advancements.

Yunyinggu

Series C in 2020
Yunyinggu Technology Co., Ltd. is a Chinese start-up focused on the development and promotion of innovative display technologies aimed at enhancing the performance of flat panel displays. The company has created a proprietary solution recognized for achieving superior pixel density, or high pixels per inch (PPI), which can be utilized across various types of flat panels, including LCD, LED, and OLED displays. By advancing display technology, Yunyinggu seeks to contribute to the evolving landscape of visual performance in consumer electronics.

Bioscience

Venture Round in 2020
Bioscience integrates R&D, manufacture, marketing and provides related technical supports for IVD instruments and reagents.

Yunyinggu

Series C in 2019
Yunyinggu Technology Co., Ltd. is a Chinese start-up focused on the development and promotion of innovative display technologies aimed at enhancing the performance of flat panel displays. The company has created a proprietary solution recognized for achieving superior pixel density, or high pixels per inch (PPI), which can be utilized across various types of flat panels, including LCD, LED, and OLED displays. By advancing display technology, Yunyinggu seeks to contribute to the evolving landscape of visual performance in consumer electronics.

Tisenc

Series C in 2019
Shenzhen Tisenc Medical Devices Co., Ltd., founded in 2015 and based in Shenzhen, China, specializes in the development, manufacture, and global sales of chemiluminescence immunology (CLIA) systems. The company focuses on producing advanced medical testing solutions, including point-of-care testing systems, diagnostic reagents, and molecular diagnostics solutions. Tisenc operates from a facility that encompasses over 16,000 square meters, featuring research and development laboratories, a GMP factory, and an instrument manufacturing site. The company holds full intellectual property rights for its products and technologies, allowing for independent research and development as well as production capabilities. Tisenc aims to provide innovative technological support to medical practitioners through its automatic chemiluminescent analyzers and diagnostic reagents, enhancing the field of medical diagnostics.

Huimei Technology

Series C in 2019
Huimei Technology develops and designs medical artificial intelligence solutions that focus on improving clinical quality. Core products - "single disease process quality management system", "Clinical Decision Support System (CDSS)" integrated evidence-based medical knowledge base, using natural language processing, deep learning and other AI techniques to process clinical big data, emergency department, hospitalization Link real-time assistance to doctors in decision-making, the advantage is to integrate the standard electronic clinical path and workflow, assist clinicians to make more personalized and effective diagnosis and treatment decisions according to the patient's condition, and promote products to the outpatient, emergency, and ward of large hospitals. application.

Mech-Mind

Series A in 2019
Mech-Mind Robotics Technologies Ltd. designs, develops, and sells hardware and software solutions for logistics industry. The company manufactures smart cameras, such as Mech-Eye Smart Camera, Mech-Eye Broad Smart Camera, and Mech-Eye Pro S Smart Camera for object recognition, depalletizing, assembly, sorting, and locating. Mech-Mind Robotics Technologies Ltd. also develops software solution that allows robotic camera to recognize objects in different shapes and different sizes. In addition, the company also manufactures logistic parcels picking solution for logistic customers. Mech-Mind Robotics Technologies Ltd. was founded in 2016 and is based in Beijing, China with additional office in Munich, Germany and sale office in Shanghai, China.

The Makers

Series B in 2018
A technology-focused media content provider Based in China.

Tisenc

Series A in 2018
Shenzhen Tisenc Medical Devices Co., Ltd., founded in 2015 and based in Shenzhen, China, specializes in the development, manufacture, and global sales of chemiluminescence immunology (CLIA) systems. The company focuses on producing advanced medical testing solutions, including point-of-care testing systems, diagnostic reagents, and molecular diagnostics solutions. Tisenc operates from a facility that encompasses over 16,000 square meters, featuring research and development laboratories, a GMP factory, and an instrument manufacturing site. The company holds full intellectual property rights for its products and technologies, allowing for independent research and development as well as production capabilities. Tisenc aims to provide innovative technological support to medical practitioners through its automatic chemiluminescent analyzers and diagnostic reagents, enhancing the field of medical diagnostics.

Heika

Series B in 2018
Heika is a black technology camera software with special effects.

PR Measurement

Series A in 2018
P&R Measurement Technology Co., Ltd., established in 2011 and based in Zhuhai, China, specializes in the research, development, and application of advanced measurement and control technology. The company provides testing and automation solutions across various sectors, including motors, household appliances, consumer electronics, and energy power. With over 300 independent intellectual property rights, P&R Measurement has earned recognition as a national high-tech enterprise and has received multiple certifications, including ISO9001:2015. The firm focuses on engineering signal processing, acoustic and vibration testing, and structural analysis, offering custom and semi-custom testing equipment and consulting services. P&R Measurement also collaborates with universities and research institutions to enhance its technological capabilities. It operates subsidiaries in multiple locations, including Guangzhou, Suzhou, Hong Kong, and the United States, and has developed comprehensive solutions that are widely acknowledged by industry clients, contributing to its reputation in the testing and automation landscape.

Bioscience

Series C in 2017
Bioscience integrates R&D, manufacture, marketing and provides related technical supports for IVD instruments and reagents.

SMTP Technology

Series A in 2016
SMTP Technology Co., Ltd. specializes in the research, development, and manufacturing of orthopedic medical instruments, with a particular emphasis on ultrasonic osteotomy surgery instruments. Established in 2011 and headquartered in Zhangjiagang, China, the company aims to enhance surgical outcomes through innovative medical devices. SMTP Technology markets its products through a network of medical product distributors, striving to offer improved solutions for both surgeons and patients in the orthopedic field.

SMTP Technology

Series A in 2015
SMTP Technology Co., Ltd. specializes in the research, development, and manufacturing of orthopedic medical instruments, with a particular emphasis on ultrasonic osteotomy surgery instruments. Established in 2011 and headquartered in Zhangjiagang, China, the company aims to enhance surgical outcomes through innovative medical devices. SMTP Technology markets its products through a network of medical product distributors, striving to offer improved solutions for both surgeons and patients in the orthopedic field.

Ants Technology

Series B in 2014
Ants Technology

Ants Technology

Series A in 2014
Ants Technology

Alltech Medical Systems

Series B in 2009
Alltech Medical Systems is a Chinese company that specializes in medical imaging technologies and solutions, particularly in the development of magnetic resonance imaging (MRI) systems and other advanced diagnostic equipment. Its primary operational hubs are located in Cleveland, USA, and Chengdu, China. The company offers a range of products, including a 1.5 T magnetic resonance system that features a multichannel data acquisition system for real-time imaging and advanced RF coils. These innovations support a variety of clinical applications and incorporate intelligent graphical user interfaces for streamlined scanning workflows. Alltech Medical Systems also develops other imaging technologies such as X-ray computed tomography, digital X-ray systems, color Doppler ultrasound, and PET-MR. With a management and technology team comprised of professionals with extensive experience in medical imaging, the company has secured over 100 international patents in the field. It aims to enhance medical imaging services in hospitals across China by integrating Internet and artificial intelligence technologies into its offerings.

Alltech Medical Systems

Series A in 2006
Alltech Medical Systems is a Chinese company that specializes in medical imaging technologies and solutions, particularly in the development of magnetic resonance imaging (MRI) systems and other advanced diagnostic equipment. Its primary operational hubs are located in Cleveland, USA, and Chengdu, China. The company offers a range of products, including a 1.5 T magnetic resonance system that features a multichannel data acquisition system for real-time imaging and advanced RF coils. These innovations support a variety of clinical applications and incorporate intelligent graphical user interfaces for streamlined scanning workflows. Alltech Medical Systems also develops other imaging technologies such as X-ray computed tomography, digital X-ray systems, color Doppler ultrasound, and PET-MR. With a management and technology team comprised of professionals with extensive experience in medical imaging, the company has secured over 100 international patents in the field. It aims to enhance medical imaging services in hospitals across China by integrating Internet and artificial intelligence technologies into its offerings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.